PRKAA1 and Insulin resistance: In line with this, 5-aminoimidazole-4-carboxamide riboside (AICAR), the most widely used pharmacological AMPK activator, which is converted within cells to the AMP-mimetic AICAR monophosphate (ZMP), improved insulin sensitivity in animal models of insulin resistance (Hardie et al., 2012).